Simpo, Elsa A.

HRN: 09-81-98  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/26/2023
CEFUROXIME 1.5GM (VIAL)
05/27/2023
05/28/2023
IV
1.5gms
On Call To OR
For TAHBSO
Waiting Final Action 
05/26/2023
CEFUROXIME 1.5GM (VIAL)
05/26/2023
05/27/2023
IV
1.5g
Q8 ANST X 3 Doses
UTI
Waiting Final Action 
05/27/2023
CEFUROXIME 1.5GM (VIAL)
05/27/2023
05/28/2023
IV
1.5gm 3 Doses
Q8
Post CS
Waiting Final Action 
05/27/2023
CEFUROXIME 500MG (TAB)
05/29/2023
06/04/2023
PO
500mg
BID
Post Cs
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: